Mohammad Hossein Kazemi
- Physiology top 2%
- Cancer Research top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Immunology top 10%
- Immune Cell Function and Interaction 6
- IL-33, ST2, and ILC Pathways 5
- Immune cells in cancer 3
-
- Hematopoietic Stem Cell Transplantation 4
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Elahe SafariShima Moradi‐KalbolandiKhadijeh BarzamanLeila FarahmandJafar KaramiZeinab Zarei‐BehjaniGhasem GhalamfarsaFarhad Jadidi‐Niaragh
- Cited by
- PhysiologyCancer ResearchOncology
- Journals
- Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- IranUnited StatesSweden
In The Last Decade
Mohammad Hossein Kazemi
36 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Physiology 138
- Cancer Research 240
- Oncology 398
- Immunology 287
- Molecular Biology 484
Countries citing papers authored by Mohammad Hossein Kazemi
This map shows the geographic impact of Mohammad Hossein Kazemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Hossein Kazemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Hossein Kazemi more than expected).
Fields of papers citing papers by Mohammad Hossein Kazemi
This network shows the impact of papers produced by Mohammad Hossein Kazemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Hossein Kazemi. The network helps show where Mohammad Hossein Kazemi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Hossein Kazemi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 10 | |
| 6 | Oncolytic Viruses: A Promising Solution for Relapse Prevention after Autologous Hematopoietic Stem Cell Transplantation | 2021 | 2 |
| 7 | 2021 | 1 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 86 | |
| 15 | 2020 | 6 | |
| 16 | Breast cancer: Biology, biomarkers, and treatmentsbreakdown → | 2020 | 566 |
| 17 | 2018 | 18 | |
| 18 | 2017 | 118 | |
| 19 | 2009 | 6 | |
| 20 | Designing of ELISA kit for diagnosis of anti-Toxoplasma specific IgG, using exerted/secreted antigens and its | 2008 | 1 |
About Mohammad Hossein Kazemi
Mohammad Hossein Kazemi is a scholar working on Hematology, Immunology and Physiology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), IL-33, ST2, and ILC Pathways (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), COVID-19 Clinical Research Studies (3 papers), CAR-T cell therapy research (3 papers), Immune cells in cancer (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Physiology (138 citations), Cancer Research (240 citations) and Oncology (398 citations). Mohammad Hossein Kazemi has collaborated with scholars based in Iran, United States and Sweden. Frequent co-authors include Elahe Safari, Shima Moradi‐Kalbolandi, Khadijeh Barzaman, Leila Farahmand, Jafar Karami, Zeinab Zarei‐Behjani, Ghasem Ghalamfarsa, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi and Hossein Khorramdelazad. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.